We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $760M
1-Year Est. Return 29.29%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+29.29%
3 Year Est. Return
+78.04%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83M
AUM Growth
-$59.9M
Cap. Flow
-$60.8M
Cap. Flow %
-73.33%
Top 10 Hldgs %
39.27%
Holding
135
New
5
Increased
33
Reduced
58
Closed
32

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$329K
2
CVX icon
Chevron
CVX
+$250K
3
T icon
AT&T
T
+$246K
4
ISRG icon
Intuitive Surgical
ISRG
+$211K
5
LYB icon
LyondellBasell Industries
LYB
+$210K

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$11.2M
2
SJB icon
ProShares Short High Yield
SJB
+$9.26M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.79M
4
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$5.78M
5
RWM icon
ProShares Short Russell2000
RWM
+$5.64M

Sector Composition

Rank Sector Weight
1 Energy 26.64%
2 Technology 13.42%
3 Healthcare 11.12%
4 Consumer Staples 11.05%
5 Financials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
76
Freeport-McMoran
FCX
$104B
$279K 0.34%
6,973
+548
+9% +$20.9K
ROK icon
77
Rockwell Automation
ROK
$48.2B
$276K 0.33%
837
– –
ADBE icon
78
Adobe
ADBE
$106B
$273K 0.33%
558
-29
-5% -$11.7K
ACN icon
79
Accenture
ACN
$114B
$262K 0.32%
848
+108
+15% +$31.4K
ZTS icon
80
Zoetis
ZTS
$31.3B
$252K 0.3%
1,465
-89
-6% -$15.4K
MRK icon
81
Merck
MRK
$371B
$250K 0.3%
2,170
-32
-1% -$3.63K
MNST icon
82
Monster Beverage
MNST
$85.8B
$248K 0.3%
8,638
-402
-4% -$11.4K
ADI icon
83
Analog Devices
ADI
$176B
$247K 0.3%
1,269
-1
-0.1% -$185
SNOW icon
84
Snowflake
SNOW
$117B
$242K 0.29%
1,375
+46
+3% +$7.48K
CRM icon
85
Salesforce
CRM
$213B
$242K 0.29%
1,144
-55
-5% -$11.2K
ETN icon
86
Eaton
ETN
$160B
$240K 0.29%
1,194
-148
-11% -$26K
ISRG icon
87
Intuitive Surgical
ISRG
$130B
$239K 0.29%
+698
New +$211K
FDX icon
88
FedEx
FDX
$76.3B
$220K 0.27%
889
– –
MRSH
89
Marsh
MRSH
$88.6B
$220K 0.27%
+1,171
New +$208K
GM icon
90
General Motors
GM
$77B
$219K 0.26%
5,688
+36
+0.6% +$1.25K
TMO icon
91
Thermo Fisher Scientific
TMO
$227B
$215K 0.26%
413
-23
-5% -$12.4K
ASML icon
92
ASML
ASML
$659B
$214K 0.26%
295
-1
-0.3% -$680
DEO icon
93
Diageo
DEO
$49.6B
$212K 0.26%
1,222
+53
+5% +$9.46K
COP icon
94
ConocoPhillips
COP
$161B
$210K 0.25%
+2,023
New +$208K
LOW icon
95
Lowe's Companies
LOW
$115B
$207K 0.25%
918
-209
-19% -$43.5K
LIN icon
96
Linde
LIN
$220B
$206K 0.25%
+541
New +$198K
TSLA icon
97
Tesla
TSLA
$1.4T
$202K 0.24%
+773
New +$155K
OKE icon
98
Oneok
OKE
$60.2B
$201K 0.24%
3,265
+5
+0.2% +$309
WBD icon
99
Warner Bros
WBD
$70.8B
$181K 0.22%
14,413
-692
-5% -$8.98K
VOD icon
100
Vodafone
VOD
$39.1B
$146K 0.18%
15,416
+2,554
+20% +$26.8K
2 3
4
5 6

Similar funds

KFAS
Keating Financial Advisory Services Manhattan, Kansas $760M AUM
EAN
Excelsior Advisor Network Denver, Colorado $759M AUM
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $759M AUM 84.08% 1-Year Est. Return
RFA
Rollins Financial Advisors New York City, New York $759M AUM 31.13% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $759M AUM 24.25% 1-Year Est. Return
HGWM
Horst & Graben Wealth Management Portland, Oregon $760M AUM 21.68% 1-Year Est. Return
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $759M AUM
DIA
Dean Investment Associates Beavercreek, Ohio $761M AUM 33.5% 1-Year Est. Return

Fourpath Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Fourpath Capital Management held 135 positions worth $83M, down 42% from $143M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fourpath Capital Management withdrew a net $60.8M in Q2 2023, closing 32 positions and reducing 58 holdings. Its most notable exit was iShares Gold Trust, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Energy at 27% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Fourpath Capital Management opened a new position in Intuitive Surgical worth $239K.

  • Fourpath Capital Management's largest Q2 2023 buy was Intuitive Surgical: 698 shares worth $239K.
  • Fourpath Capital Management added most to Amgen in Q2 2023, an estimated $329K increase.
  • Fourpath Capital Management's biggest Q2 2023 reduction was British American Tobacco, cutting an estimated $553K.
  • Fourpath Capital Management fully exited iShares Gold Trust in Q2 2023, selling an estimated $11.2M.
  • Fourpath Capital Management's ten largest holdings make up 39% of its $83M portfolio in Q2 2023.
  • Fourpath Capital Management opened 5 new positions and closed 32 in Q2 2023.
  • Fourpath Capital Management's portfolio value fell 42% quarter-over-quarter to $83M.

Based on Fourpath Capital Management's 13F filing for Q2 2023, filed 7 Aug 2023.